Inhibition of HIV-1 or bacterial activation of macrophages by products of HIV-1-resistant human cells

Immunology and Cell Biology

Volumn 85, Issue 8, 2007, Pages 603-609

  Li, Guanhua ^a   Aaron, Sagiv ^a   Kazmierczak, Katarzyna ^a   Lesner, Adam ^a   Li, Yuchang ^a   Ivanova, Anna ^a   Bentsman, Galina ^a   Potash, Mary Jane ^a   Simm, Malgorzata ^a,b  

^a NewYork Presbyterian Hospital   (United States)

^b ST LUKE S ROOSEVELT HOSPITAL CENTER   (United States)

Author keywords

Human; Inflammation; Lipopolysaccharide; Macrophages; Transcription factors

Indexed keywords

ANTIVIRUS AGENT; BACTERIAL ANTIGEN; HIV 1 RECEPTOR FACTOR; IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; LIPOPOLYSACCHARIDE; TUMOR NECROSIS FACTOR ALPHA; UNCLASSIFIED DRUG;

ANIMAL CELL; ANTIVIRAL ACTIVITY; ARTICLE; BLOOD CULTURE; CELL ACTIVITY; CONTROLLED STUDY; DNA BINDING; EXPOSURE; HUMAN; HUMAN CELL; HUMAN IMMUNODEFICIENCY VIRUS 1; HUMAN IMMUNODEFICIENCY VIRUS 1 INFECTION; MACROPHAGE; MICROBIAL ACTIVITY; NONHUMAN; PATHOGENESIS; PERIPHERAL LYMPHOCYTE; R FACTOR; VIRUS EXPRESSION; VIRUS RESISTANCE;

BACTERIA; CELL NUCLEUS; DIMERIZATION; DNA; HIV-1; HUMANS; INFLAMMATION; LIPOPOLYSACCHARIDES; MACROPHAGE ACTIVATION; MACROPHAGES; NF-KAPPA B; PROTEIN BINDING; PROTEIN TRANSPORT; TRANSCRIPTION FACTOR RELA; VIRUS REPLICATION;

BACTERIA (MICROORGANISMS); HUMAN IMMUNODEFICIENCY VIRUS 1;

EID: 36849080461     PISSN: 08189641     EISSN: 14401711     Source Type: Journal    
DOI: 10.1038/sj.icb.7100092     Document Type: Article

References (37)

1. Cerami A. Tumor necrosis factor as a mediator of shock, cachexia and inflammation. Blood Purif 1993; 11: 108-117.
2. Hazen RJ, Harvey RJ, St Clair MH, Ferris RG, Freeman GA, Tidwell JH et al. Anti-human immunodeficiency virus type 1 activity of the nonnucleoside reverse transcriptase inhibitor GW678248 in combination with other antiretrovirals against clinical isolate viruses and in vitro selection for resistance. Antimicrob Agents Chemother 2005; 49: 4465-4473.
3. Leonard JN, Schaffer DV. Computational design of antiviral RNA interference strategies that resist human immunodeficiency virus escape. J Virol 2005; 79: 1645-1654.
4. Poveda E, Briz V, Soriano V. Enfuvirtide, the first fusion inhibitor to treat HIV infection. AIDS Rev 2005; 7: 139-147.
5. Wainberg MA, Sawyer JP, Montaner JS, Murphy RL, Kuritzkes DR, Raffi F. Challenges for the clinical development of new nucleoside reverse transcriptase inhibitors for HIV infection. Antivir Ther 2005; 10: 13-28.
6. Kelly LM, Lisziewicz J, Lori F. 'Virostatics' as a potential new class of HIV drugs. Curr Pharm Des 2004; 10: 4103-4120.
7. Lesner A, Kartvelishvili A, Lesniak J, Nikolov D, Kartvelishvili M, Trillo-Pazos G et al. Monoubiquitinated histone H1B is required for antiviral protection in CD4(+)T cells resistant to HIV-1. Biochemistry 2004; 43: 16203-16211.
8. Lesner A, Li Y, Nitkiewicz J, Li G, Kartvelishvili A, Kartvelishvili M et al. A soluble factor secreted by an HIV-1-resistant cell line blocks transcription through inactivating the DNA-binding capacity of the NF-kappa B p65/p50 dimer. J Immunol 2005; 175: 2548-2554.
9. Simm M, Miller LS, Durkin HG, Allen M, Chao W, Lesner A et al. Induction of secreted human immunodeficiency virus type 1 (HIV-1) resistance factors in CD4-positive T lymphocytes by attenuated HIV-1 infection. Virology 2002; 294: 1-12.
10. Simm M, Pekarskaya O, Potash MJ, Volsky DJ. Prolonged infection of peripheral blood lymphocytes by Vif-negative HIV type 1 induces resistance to productive HIV type 1 infection through soluble factors. AIDS Res Hum Retroviruses 2000; 16: 943-952.
11. Simm M, Pekarskaya O, Volsky DJ. Synthesis of full-length viral DNA in CD4-positive membrane vesicles exposed to HIV-1. A model for studies of early stages of the hiv-1 life cycle. J Biol Chem 1996; 271: 28266-28270.
12. Choe W, Volsky DJ, Potash MJ. Induction of rapid and extensive beta-chemokine synthesis in macrophages by human immunodeficiency virus type 1 and gp120, independently of their coreceptor phenotype. J Virol 2001; 75: 10738-10745.
13. Choe W, Volsky DJ, Potash MJ. Activation of NF-kappaB by R5 and X4 human immunodeficiency virus type 1 induces macrophage inflammatory protein 1alpha and tumor necrosis factor alpha in macrophages. J Virol 2002; 76: 5274-5277.
14. Voraberger G, Schafer R, Stratowa C. Cloning of the human gene for intercellular adhesion molecule 1 and analysis of its 5′-regulatory region. Induction by cytokines and phorbol ester. J Immunol 1991; 147: 2777-2786.
15. Guillemard E, Jacquemot C, Aillet F, Schmitt N, Barre-Sinoussi F, Israel N. Human immunodeficiency virus 1 favors the persistence of infection by activating macrophages through TNF. Virology 2004; 329: 371-380.
16. Swords WE, Guenthner PC, Birkness KA, Lal RB, Dezzutti CS, Quinn FD. Mycobacterium xenopi multiplies within human macrophages and enhances HIV replication in vitro. Microb Pathog 2006; 40: 41-47.
17. Rosas-Taraco AG, Arce-Mendoza AY, Caballero-Olin G, Salinas-Carmona MC. Mycobacterium tuberculosis upregulates coreceptors CCR5 and CXCR4 while HIV modulates CD14 favoring concurrent infection. AIDS Res Hum Retroviruses 2006; 22: 45-51.
18. Huang Y, Erdmann N, Zhao J, Zheng J. The signaling and apoptotic effects of TNF-related apoptosis-inducing ligand in HIV-1 associated dementia. Neurotox Res 2005; 8: 135-148.
19. Kartvelishvili A, Lesner A, Szponar M, Simm M. Microarray analysis of differentially expressed genes in cells resistant to HIV-1. Immunol Lett 2004; 93: 79-86.
20. Simm M, Su Z, Huang EY, Chen Y, Jiang H, Volsky DJ et al. Cloning of differentially expressed genes in an HIV-1 resistant T cell clone by rapid subtraction hybridization, RaSH. Gene 2001; 269: 93-101.
21. Su ZZ, Chen Y, Kang DC, Chao W, Simm M, Volsky DJ et al. Customized rapid subtraction hybridization (RaSH) gene microarrays identify overlapping expression changes in human fetal astrocytes resulting from human immunodeficiency virus-1 infection or tumor necrosis factor-alpha treatment. Gene 2003; 306: 67-78.
22. Aguilar-Cordova E, Chinen J, Donehower L, Lewis DE, Belmont JW. A sensitive reporter cell line for HIV-1 tat activity, HIV-1 inhibitors, and T cell activation effects. AIDS Res Hum Retroviruses 1994; 10: 295-301.
23. Gendelman HE, Orenstein JM, Martin MA, Ferrua C, Mitra R, Phipps T et al. Efficient isolation and propagation of human immunodeficiency virus on recombinant colony-stimulating factor 1-treated monocytes. J Exp Med 1988; 167: 1428-1441.
24. Adachi A, Gendelman HE, Koenig S, Folks T, Willey R, Rabson A et al. Production of acquired immunodeficiency syndrome-associated retrovirus in human and nonhuman cells transfected with an infectious molecular clone. J Virol 1986; 59: 284-291.
25. Sattentau QJ, Clapham PR, Weiss RA, Beverley PC, Montagnier L, Alhalabi MF et al. The human and simian immunodeficiency viruses HIV-1, HIV-2 and SIV interact with similar epitopes on their cellular receptor, the CD4 molecule. Aids 1988; 2: 101-105.
26. Sattentau QJ, Weiss RA. The CD4 antigen: physiological ligand and HIV receptor. Cell 1988; 52: 631-633.
27. Feldmann M, Brennan FM, Elliott MJ, Williams RO, Maini RN. TNF alpha is an effective therapeutic target for rheumatoid arthritis. Ann N Y Acad Sci 1995; 766: 272-278.
28. Schattner A. Lymphokines in autoimmunity - a critical review. Clin Immunol Immunopathol 1994; 70: 177-189.
29. Tracey KJ. Tumor necrosis factor (cachectin) in the biology of septic shock syndrome. Circ Shock 1991; 35: 123-128.
30. Tracey KJ, Cerami A. Tumor necrosis factor: a pleiotropic cytokine and therapeutic target. Annu Rev Med 1994; 45: 491-503.
31. Dong C, Nurieva RI, Prasad DV. Immune regulation by novel costimulatory molecules. Immunol Res 2003; 28: 39-48.
32. Janeway Jr CA, Medzhitov R. Innate immune recognition. Annu Rev Immunol 2002; 20: 197-216.
33. Shimizu T, Sano C, Tomioka H. The role of B7 molecules in the cell contact-mediated suppression of T cell mitogenesis by immunosuppressive macrophages induced with mycobacterial infection. Clin Exp Immunol 2004; 135: 373-379.
34. Potash MJ, Chao W, Bentsman G, Paris N, Saini M, Nitkiewicz J et al. A mouse model for study of systemic HIV-1 infection, antiviral immune responses, and neuroinvasiveness. Proc Natl Acad Sci USA 2005; 102: 3760-3765.
35. Beutler B, Milsark IW, Cerami AC. Passive immunization against cachectin/tumor necrosis factor protects mice from lethal effect of endotoxin. Science 1985; 229: 869-871.
36. Miethke T, Gaus H, Wahl C, Heeg K, Wagner H. T-cell-dependent shock induced by a bacterial superantigen. Chem Immunol 1992; 55: 172-184.
37. Miethke T, Wahl C, Heeg K, Echtenacher B, Krammer PH, Wagner H. T cell-mediated lethal shock triggered in mice by the superantigen staphylococcal enterotoxin B: critical role of tumor necrosis factor. J Exp Med 1992; 175: 91-98.